Patents by Inventor Erin O'Brien

Erin O'Brien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RESPIRE 1
    Publication number: 20240188830
    Abstract: The present invention relates to the use of imaging for non-invasive and non-contact measurement of respiration rates and body temperature. The invention uses a combination of visible imaging, thermal imaging, and machine learning to monitor respiration rate and body temperature. One of the embodiments of the invention allows the invention to be mounted on an articulating arm for use in hospital settings. Another embodiment of the invention allows the invention to be easily portable for use in mobile applications. Further embodiments allow the system to be used remotely making it very applicable for use in isolation or for remote locations.
    Type: Application
    Filed: April 15, 2023
    Publication date: June 13, 2024
    Applicant: LeTourneau University
    Inventors: Maxx Frick, Charles Cook, Devon Cuperus, Drake Dunn, Lindsey Greene, Gabriel Hurlbert, Joon W. Kim, Christin Kelly, Andrew Lang, Katherine Le, Sungyub Lew, Grace Nakano, Sean Nutt, Alistair Park, Zachary Poorman, Savannah Orton, Julian Lee, Erin O'Brien, Ashley DeCock, Morgan Nix, Evan Kowal, Samson Segovia, Ian Crochet, Oladimeji Apaokagi
  • Methods for increasing T-cell function
    Patent number: 11879003
    Abstract: Provided herein are methods of increasing T-cell function and T-cells produced by these methods. Also provided herein are methods of treating a subject using T-cells produced by these methods.
    Type: Grant
    Filed: October 21, 2022
    Date of Patent: January 23, 2024
    Assignee: Kyverna Therapeutics, Inc.
    Inventors: John Lee, Erin O'Brien, Jordan Tsai, Lih-Yun Hsu, Faye Wu
  • METHODS FOR INCREASING T-CELL FUNCTION
    Publication number: 20230174615
    Abstract: Provided herein are methods of increasing T-cell function and T-cells produced by these methods. Also provided herein are methods of treating a subject using T-cells produced by these methods.
    Type: Application
    Filed: October 21, 2022
    Publication date: June 8, 2023
    Applicant: Kyverna Therapeutics, Inc.
    Inventors: John Lee, Erin O'Brien, Jordan Tsai, Lih-Yun Hsu, Faye Wu
  • METHODS AND COMPOSITIONS FOR TREATING DISEASE USING TARGETED FOXP3+CD4+ T CELLS AND CELLULAR SUICIDE AGENTS
    Publication number: 20230056336
    Abstract: This document relates to methods and materials for treating a mammal having an autoimmune disease. For example, materials and methods for producing a T cell comprising a FOXP3 polypeptide and a cellular suicide agent are provided herein. Methods and materials for treating a mammal having an autoimmune disease comprising administering to a mammal having an autoimmune disease an effective amount of a T cell are also provided herein.
    Type: Application
    Filed: April 15, 2022
    Publication date: February 23, 2023
    Inventors: Lih-Yun Hsu, Faye Wu, Jeffrey Greve, Erin O'Brien, Jeanne Flandez, John Lee